Yahoo Web Search

  1. Mihael Polymeropoulos has been the CEO of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) since 2003. This analysis aims first to contrast CEO compensation with other companies ...

  2. PDUFA dates are deadlines for the FDA to review new drugs. The FDA is normally given 10 months to review new drugs. If a drug is selected for priority review, the FDA is allotted six months to review the drug.

  1. Ads
    related to Vanda Pharmaceuticals Inc